Carl Walkey
Keine laufenden Positionen mehr
Profil
Carl Walkey is the founder of Ansible Marketing, Inc. (founded in 2014) and Neoleukin Therapeutics, Inc. (founded in 2003).
At Neoleukin Therapeutics, he held the title of Senior Vice President-Corporate Development from 2021 to 2022.
Dr. Walkey earned a doctorate degree from the University of Toronto.
Ehemalige bekannte Positionen von Carl Walkey
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROGENE INC. | Founder | 01.12.2022 |
| Ansible Marketing, Inc. | Founder | - |
Ausbildung von Carl Walkey
| University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
| Ansible Marketing, Inc. |
